Change over period: —
NSE · PIIND
PI INDUS.LTD
-54.7% from the 52-week high · +0.0% above the low
PI Industries Ltd. engages in the manufacturing and selling of agro-inputs, which comprises of crop protection chemicals and plant growth nutrients. The company is headquartered in Gurgaon, Haryana and currently employs 3,384 full-time employees. The company went IPO on 2011-06-14. The firm is engaged in the manufacturing and distribution of agro chemicals. The company operates through Agro Chemicals segment. The firm offers two products categories: agro chemical products and specialty products. Its agrochemical products categories include insecticides, fungicides and herbicides. Its specialty products brands include Biovita Granules, Biovita Liquid, Super Spreader and Humesol. The firm offers services, such as research and development (RandD) services, CSM services, distribution services. The R and D services comprise of Target, Discovery, Molecule Design, Library Synthesis, Lead Optimization, Biological Evaluation and Route Synthesis. The company also provides Shield (fungicide) and Londax Power (rice herbicide) products. The firm provides services in various areas, including contract research, process development, analytical method development, process safety data generation and process detailed engineering.
The short version. PI INDUS.LTD reported revenue of ₹1,702 crore for Sep 2026, down 9.1% from a year earlier. Net profit was ₹122 crore (down 70.2% year on year). Return on equity was 11.8% in Mar 2026. Promoter holding was 46.09% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
PI INDUS.LTD trades 54.7% below its 52-week high and 0.0% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹1,702 cr.
Sep 2026 net profit of ₹122 cr.
14.7 pts lower than a year earlier.
Revenue compounded at 1.8% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1702 | 1702 | 1565 | 1376 | 1872 | 1900 | 1787 | 1901 |
| Net profit | 122 | 244 | 200 | 311 | 409 | 400 | 330 | 373 |
| Net margin % | 7.2 | 14.3 | 12.8 | 22.6 | 21.9 | 21.0 | 18.5 | 19.6 |
| EPS (₹) | 8.05 | 16.1 | 13.2 | 20.52 | 26.98 | 26.36 | 21.78 | 24.57 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6714 | 7978 | 7666 | 6492 | 5300 | 4577 | 3366 | 2841 |
| Net profit | 1321 | 1660 | 1682 | 1230 | 844 | 738 | 457 | 410 |
| Net margin % | 19.7 | 20.8 | 21.9 | 18.9 | 15.9 | 16.1 | 13.6 | 14.4 |
| EPS (₹) | 87.06 | 109.43 | 110.83 | 81.04 | 55.62 | 48.66 | 33.06 | 29.72 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 11.8% in Mar 2026; debt to equity is 0.02.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 11.8 | 16.4 | 19.3 | 17.1 |
| Return on capital % | 14.6 | 20.6 | 21.1 | 20.2 |
| EBITDA margin % | 30.1 | 30.3 | 28.2 | 25.6 |
| Net margin % | 18.8 | 20.0 | 21.4 | 18.5 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 1.8% | 8.4% |
| Profit CAGR | 2.4% | 12.3% |
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Down 3.68 pts over 8 quarters.
Up 4.31 pts over 8 quarters.
+33 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 46.09 | 46.09 | 46.09 | 46.09 | 46.09 | 46.09 | 46.09 | 46.09 | 0.0 |
| FII | 18.46 | 18.05 | 16.97 | 16.42 | 15.97 | 15.87 | 14.83 | 14.78 | -3.68 |
| DII | 27.21 | 27.57 | 29.35 | 30.4 | 31.08 | 31.35 | 31.64 | 31.52 | +4.31 |
| Public | 8.23 | 8.28 | 7.58 | 7.08 | 6.86 | 6.69 | 7.44 | 7.6 | -0.63 |
Mutual fund holdings · Oct 2026
183 schemes hold this stock
150 the month before.
- Kotak Nifty Chemicals ETF5.14% of NAV
- Groww Nifty Chemicals ETF5.13% of NAV
- Invesco India Nifty Chemical Index Fund5.04% of NAV
- TATA LARGE & MID CAP FUND3.23% of NAV
- ICICI Prudential Balanced Hybrid Fund2.73% of NAV
- ICICI Prudential MNC Fund2.46% of NAV
- ICICI Prudential Quant Fund2.4% of NAV
- Taurus Mid Cap Fund2.09% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for PI INDUS.LTD are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Fertilizers & Agrochemicals stocks
Quick answers
Common questions about PI INDUS.LTD
What is the PI INDUS.LTD share price?
PI INDUS.LTD (PIIND) last closed at ₹1,639.50, up 0.95% on the day. Its 52-week range is ₹1,624.00 to ₹3,588.90.
What is the market cap of PI INDUS.LTD?
PI INDUS.LTD has a market capitalisation of about ₹24,622 crore. Its price-to-earnings ratio is 27.9.
How are PI INDUS.LTD's latest results?
PI INDUS.LTD reported revenue of ₹1,702 crore for Sep 2026, down 9.1% from a year earlier. Net profit was ₹122 crore (down 70.2% year on year). Return on equity was 11.8% in Mar 2026. Promoter holding was 46.09% in Sep 2026, up 0.00 points over 8 quarters.
Who owns PI INDUS.LTD?
As of Sep 2026, shareholding was: Promoter 46.09%, FII 14.78%, DII 31.52%, Public 7.6%.
How many mutual funds hold PI INDUS.LTD?
183 mutual fund schemes held PI INDUS.LTD in October 2026. That compares with 150 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 23 Feb 2026 · Interim Dividend - Rs. 5
- 07 Aug 2025 · Final Dividend - Rs. 10
- 14 Feb 2025 · Interim Dividend - Rs. 6
- 20 Aug 2024 · Final Dividend - Rs. 9
- 21 Feb 2024 · Interim Dividend - Rs. 6
- 11 Aug 2023 · Final Dividend - Rs. 5.5
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.